Related Experiment Video
Updated: Jun 26, 2026

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive
Mario Augusto Rojas1, Juan Manuel Lozano, Maria Ximena Rojas
1Vanderbilt University, Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Nashville, TN 37232-2370, USA. mario.a.rojas@vanderbilt.edu
Insights
Very early surfactant therapy in premature infants receiving nasal continuous positive airway pressure reduces the need for mechanical ventilation and air-leak syndrome. This approach is safe and may decrease chronic lung disease in neonates.
Area of Science:
- Neonatal Medicine
- Pediatric Pulmonology
- Critical Care
Background:
- Chronic lung disease is a major complication of premature birth, often linked to mechanical ventilation.
- Nasal continuous positive airway pressure (nCPAP) is used to avoid mechanical ventilation in premature infants.
- Surfactant therapy, typically for ventilated infants, may benefit those receiving nCPAP.
Purpose of the Study:
- To assess if very early surfactant therapy without mandatory ventilation improves outcomes in premature infants on nCPAP.
- To determine if this strategy reduces the need for mechanical ventilation in very premature infants.
Main Methods:
- A randomized, controlled trial involving 279 infants (27-31 weeks gestation) across eight centers.
- Infants received either nCPAP alone (control) or nCPAP with brief intubation for very early surfactant administration (treatment).
- The primary outcome was the need for subsequent mechanical ventilation.
Main Results:
- The treatment group showed a lower need for mechanical ventilation (26% vs. 39%) and less air-leak syndrome (2% vs. 9%).
- Fewer infants in the treatment group required surfactant after the first hour (12% vs. 26%).
- Chronic lung disease incidence was lower in the treatment group (49% vs. 59%), with similar mortality and major morbidities.
Conclusions:
- Very early surfactant therapy combined with nCPAP is safe and effective in reducing mechanical ventilation needs in premature infants.
- This intervention decreases air-leak syndrome and shows a trend towards reduced chronic lung disease.
- The findings are significant for resource-limited settings, potentially improving long-term outcomes for neonates.
Background:
Chronic lung disease is one of the most frequent and serious complications of premature birth. Because mechanical ventilation is a major risk factor for chronic lung disease, the early application of nasal continuous positive airway pressure has been used as a strategy for avoiding mechanical ventilation in premature infants. Surfactant therapy improves the short-term respiratory status of premature infants, but its use is traditionally limited to infants being mechanically ventilated. Administration of very early surfactant during a brief period of intubation to infants treated with nasal continuous positive airway pressure may improve their outcome and further decrease the need for mechanical ventilation.
Objective:
Our goal was to determine if very early surfactant therapy without mandatory ventilation improves outcome and decreases the need for mechanical ventilation when used in very premature infants treated with nasal continuous positive airway pressure soon after birth.
Design/Methods:
Eight centers in Colombia participated in this randomized, controlled trial. Infants born between 27 and 31 weeks' gestation with evidence of respiratory distress and treated with supplemental oxygen in the delivery room were randomly assigned within the first hour of life to intubation, very early surfactant, extubation, and nasal continuous positive airway pressure (treatment group) or nasal continuous airway pressure alone (control group). The primary outcome was the need for subsequent mechanical ventilation using predefined criteria.
Results:
From January 1, 2004, to December 31, 2006, 279 infants were randomly assigned, 141 to the treatment group and 138 to the control group. The need for mechanical ventilation was lower in the treatment group (26%) compared with the control group (39%). Air-leak syndrome occurred less frequently in the treatment group (2%) compared with the control group (9%). The percentage of patients receiving surfactant after the first hour of life was also significantly less in the treatment group (12%) compared with the control group (26%). The incidence of chronic lung disease (oxygen treatment at 36 weeks' postmenstrual age) was 49% in the treatment group compared with 59% in the control group. All other outcomes, including mortality, intraventricular hemorrhage, and periventricular leukomalacia were similar between the groups.
Conclusions:
In premature infants treated with nasal continuous positive airway pressure early after birth, the addition of very early surfactant therapy without mandatory ventilation decreased the need for subsequent mechanical ventilation, decreased the incidence of air-leak syndrome, and seemed to be safe. Reduction in the need for mechanical ventilation is an important outcome when medical resources are limited and may result in less chronic lung disease in both developed and developing countries.
Related Concept Videos
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation (NIPPV)
Breathing
Ventilatory Modes
There are three ventilatory modes: full support, partial support, and spontaneous. These are described below.
Full Support Modes
Full support modes include controlled mechanical ventilation, continuous mandatory...
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Cardiopulmonary Resuscitation II: ACLS Airway Management
Mechanical Ventilation I: Indication and Settings